We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Must Face EpiPen Suit Citing RICO Violations
Mylan Must Face EpiPen Suit Citing RICO Violations
Mylan and three pharmacy benefit managers — CVS Caremark, Express Scripts and OptumRx — must face a class-action lawsuit claiming that the drugmaker paid bribes and kickbacks to the three companies to ensure a monopoly market for EpiPen, a federal judge has ruled.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor